Angiodynamics (ANGO) Other Operating Expenses (2010 - 2026)

Angiodynamics' Other Operating Expenses history runs 17 years deep, the most recent figure standing at -$50.1 million for Q2 2026.

• Quarterly Other Operating Expenses changed N/A year-over-year to -$50.1 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $8.4 million (changed N/A YoY) and the FY2024 annual result came in at $54.5 million, changed N/A from the prior year.
• Other Operating Expenses was -$50.1 million for Q2 2026 at Angiodynamics, down from $17.3 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $47.8 million in Q3 2023 and bottomed at -$50.1 million in Q2 2026.
• A 5-year average of $5.3 million and a median of $11.4 million in 2022 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 48.61% in 2022, while the deepest fall reached 214.64% in 2022.
• Angiodynamics' Other Operating Expenses stood at -$32.7 million in 2022, then jumped by 246.44% to $47.8 million in 2023, then slumped by 86.09% to $6.7 million in 2024, then surged by 56.39% to $10.4 million in 2025, then tumbled by 581.35% to -$50.1 million in 2026.
• Business Quant data shows ANGO's Other Operating Expenses at -$50.1 million in Q2 2026, $17.3 million in Q1 2026, and $10.4 million in Q4 2025.